— Know what they know.
Not Investment Advice

ABMT OTC

Advanced BioMedical Technologies Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +25.0% 1Y: +400.0% 3Y: -98.8% 5Y: -99.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 51 · $50000 mcap · 99M float · 0.0001% daily turnover

Balance Sheet Trends

Total Assets
$396K -11.8% ▼
5Y CAGR: +35.9%
Total Liabilities
$8M -5.7% ▼
5Y CAGR: +10.4%
Shareholders Equity
-$8M +5.3% ▲
Cash & Investments
$5K -86.9% ▼
5Y CAGR: -8.3%
Total Debt
$7M -1.1% ▼
5Y CAGR: +12.6%
Net Debt
$7M -0.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$7K$6K$202K$37K$5K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$7K$6K$202K$37K$5K
Net Receivables$33K$50K$29K$0$0
Inventory$0$64K$100K$189K$248K
Other Current Assets$0$0$0$76K$40K
Total Current Assets$40K$119K$331K$302K$292K
Property, Plant & Equip.$103K$99K$138K$146K$103K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$103K$99K$138K$146K$103K
Total Assets$142K$218K$469K$449K$396K
— Liabilities —
Accounts Payable$33K$2K$234$2K$278
Short-Term Debt$4M$5M$5M$7M$7M
Deferred Revenue$0$136K$1M$1M$835K
Other Current Liabilities-$4M$1M$1M$698K$686K
Total Current Liabilities$6M$7M$8M$9M$8M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$7K$0$0
Total Liabilities$6M$7M$8M$9M$8M
— Equity —
Common Stock$696$698$702$706$709
Retained Earnings-$9M-$10M-$10M-$11M-$12M
Accumulated OCI$273K$334K$21K-$270K$661K
Total Stockholders Equity-$6M-$6M-$7M-$8M-$8M
Total Liabilities & Equity$142K$218K$469K$449K$396K
— Key Metrics —
Total Debt$4M$5M$5M$7M$7M
Net Debt$4M$5M$5M$7M$7M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms